Fisher, Miles, Glasgow Royal Infirmary

• British Journal of Diabetes Vol. 21 No. 2 (2021): December 2021 - Current Topics
  Series: Cardiovascular outcome trials for diabetes drugs Canagliflozin and the CANVAS Program, dapagliflozin and DECLARE-TIMI 58, ertugliflozin and VERTIS CV
  Abstract  PDF  HTML
• British Journal of Diabetes Vol. 22 No. 1 (2022): June 2022 - Current Topics
  Series: Cardiovascular outcome trials for diabetes drugs. Linagliptin, CARMELINA and CAROLINA
  Abstract  PDF  HTML
• British Journal of Diabetes Vol. 22 No. 2 (2022): December 2022 - Current Topics
  Series: Cardiovascular outcome trials for diabetes drugs.
  Abstract  PDF  HTML
• British Journal of Diabetes Vol. 20 No. 1 (2020): June 2020 - Current Topics
  Series: Cardiovascular outcome trials for diabetes drugs Lixisenatide and ELIXA
  Abstract  PDF  HTML
• British Journal of Diabetes Vol. 20 No. 1 (2020): June 2020 - Current Topics
  Series: Cardiovascular outcome trials for diabetes drugs Sitagliptin and TECOS
  Abstract  PDF  HTML
• British Journal of Diabetes Vol. 20 No. 2 (2020): December 2020 - Current Topics
  Series: Cardiovascular outcome trials for diabetes drugs Empagliflozin and EMPA-REG OUTCOME
  Abstract  PDF  HTML
• British Journal of Diabetes Vol. 20 No. 2 (2020): December 2020 - Current Topics
  Series: Cardiovascular outcome trials for diabetes drugs Liraglutide and LEADER
  Abstract  PDF  HTML
• British Journal of Diabetes Vol. 21 No. 1 (2021): June 2021 - Current Topics
  Series: Cardiovascular outcome trials for diabetes drugs Semaglutide and SUSTAIN-6
  Abstract  PDF  HTML
• British Journal of Diabetes Vol. 21 No. 1 (2021): June 2021 - Current Topics
  Series: Cardiovascular outcome trials for diabetes drugs Degludec and DEVOTE
  Abstract  PDF  HTML
• British Journal of Diabetes Vol. 18 No. 1 (2018): January / February / March 2018 - Reviews
  Cardiovascular outcomes trials with statins in diabetes
  Abstract  HTML  PDF
• British Journal of Diabetes Vol. 18 No. 3 (2018): July / August / September 2018 - Reviews
  Cardiovascular outcomes trials with non-statin lipid-lowering drugs in diabetes
  Abstract  PDF  HTML